Christopher D. Floyd

1.4k total citations · 1 hit paper
11 papers, 1.2k citations indexed

About

Christopher D. Floyd is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Christopher D. Floyd has authored 11 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 5 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Christopher D. Floyd's work include Protease and Inhibitor Mechanisms (4 papers), Peptidase Inhibition and Analysis (3 papers) and Chemical Synthesis and Analysis (2 papers). Christopher D. Floyd is often cited by papers focused on Protease and Inhibitor Mechanisms (4 papers), Peptidase Inhibition and Analysis (3 papers) and Chemical Synthesis and Analysis (2 papers). Christopher D. Floyd collaborates with scholars based in United Kingdom. Christopher D. Floyd's co-authors include Mark Whittaker, Peter de Nully Brown, A. J. H. Gearing, Sanjay R. Patel, Ian Fleming, H Lewis, Catherine Leblanc, Ian H. Gilbert, Raffaella Di Lucrezia and Alan H. Davidson and has published in prestigious journals such as Chemical Reviews, Biochemical Pharmacology and Tetrahedron Letters.

In The Last Decade

Christopher D. Floyd

11 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

1999 851 citations Mark Whittaker, Christopher D. Floyd et al. Chemical Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher D. Floyd United Kingdom	8	623	523	481	477	99	11	1.2k
Jerauld S. Skotnicki United States	22	934 1.5×	466 0.9×	385 0.8×	530 1.1×	107 1.1×	51	1.7k
LR Kelland United Kingdom	21	843 1.4×	927 1.8×	141 0.3×	425 0.9×	59 0.6×	37	1.7k
Carlo Gallina Italy	17	318 0.5×	233 0.4×	219 0.5×	319 0.7×	71 0.7×	41	707
Philip G. Penketh United States	24	814 1.3×	190 0.4×	299 0.6×	304 0.6×	67 0.7×	60	1.3k
William A. Denny New Zealand	18	640 1.0×	361 0.7×	164 0.3×	731 1.5×	47 0.5×	21	1.4k
David M. Ryckman United States	18	1.3k 2.1×	413 0.8×	137 0.3×	423 0.9×	75 0.8×	31	1.8k
Alfonso de Dios Spain	18	494 0.8×	1.0k 1.9×	186 0.4×	440 0.9×	29 0.3×	38	1.8k
Kanami Yamazaki Japan	17	892 1.4×	334 0.6×	203 0.4×	238 0.5×	51 0.5×	27	1.4k
James B. Doherty United States	19	455 0.7×	234 0.4×	186 0.4×	646 1.4×	52 0.5×	36	1.1k
Siavosh Mahboobi Germany	26	1.0k 1.7×	369 0.7×	120 0.2×	858 1.8×	183 1.8×	76	1.8k

Countries citing papers authored by Christopher D. Floyd

Since Specialization

Citations

This map shows the geographic impact of Christopher D. Floyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Floyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Floyd more than expected).

Fields of papers citing papers by Christopher D. Floyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Floyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Floyd. The network helps show where Christopher D. Floyd may publish in the future.

Co-authorship network of co-authors of Christopher D. Floyd

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Floyd. A scholar is included among the top collaborators of Christopher D. Floyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Floyd. Christopher D. Floyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Whittaker, Mark, Christopher D. Floyd, Peter de Nully Brown, & A. J. H. Gearing. (2001). Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors. (Chem. Rev. 1999, 99, 2735−2776. Published on the Web September 8, 1999).. Chemical Reviews. 101(7). 2205–2206. 58 indexed citations

2.

Lucrezia, Raffaella Di, Ian H. Gilbert, & Christopher D. Floyd. (2000). Solid Phase Synthesis of Purines from Pyrimidines. Journal of Combinatorial Chemistry. 2(3). 249–253. 32 indexed citations

3.

Floyd, Christopher D., Catherine Leblanc, & Mark Whittaker. (1999). 3 Combinatorial Chemistry as a Tool for Drug Discovery. Progress in medicinal chemistry. 36. 91–168. 39 indexed citations

4.

Whittaker, Mark, Christopher D. Floyd, Peter de Nully Brown, & A. J. H. Gearing. (1999). Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors. Chemical Reviews. 99(9). 2735–2776. 851 indexed citations breakdown →

5.

Whittaker, Mark, Christopher D. Floyd, Peter de Nully Brown, & A. J. H. Gearing. (1999). ChemInform Abstract: Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors. ChemInform. 30(48). 1 indexed citations

6.

Floyd, Christopher D., et al.. (1998). Rapid Synthesis of Matrix Metalloproteinase Inhibitors via Ugi Four-Component Condensation. Synlett. 1998(6). 637–639. 20 indexed citations

7.

Floyd, Christopher D., H Lewis, Sanjay R. Patel, & Mark Whittaker. (1996). A method for the synthesis of hydroxamic acids on solid phase. Tetrahedron Letters. 37(44). 8045–8048. 88 indexed citations

8.

Allanson, Nigel M., et al.. (1994). The synthesis of novel mimics of the sialyl Lewis X determinant. Tetrahedron Asymmetry. 5(11). 2061–2076. 20 indexed citations

9.

Whittaker, Mark, Michael R. Price, A. L. Miller, et al.. (1993). Cyclic ether acetal platelet activating factor (PAF) receptor antagonists I: 3-pyridyl derivatives. Bioorganic & Medicinal Chemistry Letters. 3(8). 1493–1498. 7 indexed citations

10.

Booth, R. F. G., et al.. (1990). A structurally novel inhibitor of cGMP phosphodiesterase with vasodilator activity. Biochemical Pharmacology. 40(10). 2315–2321. 3 indexed citations

11.

Fleming, Ian & Christopher D. Floyd. (1981). The reactions of tris(trimethylsilyl)methyl-lithium with some carbon electrophiles. Journal of the Chemical Society Perkin Transactions 1. 969–969. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact